HD Biosciences

company

About

Drug discovery contract research

  • 251 - 500

Details

Last Funding Type
Series A
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2002
Number Of Employee
251 - 500
Operating Status
Active

HD Biosciences Inc. (HDB) is a Shanghai-based biotech company specializing in drug discovery contract research. HDB has developed extensive knowledge and comprehensive technology platforms for drug discovery including assay development, high throughput drug screening, SAR, closed-loop and hit-to-lead biology solutions, as well as natural product-based lead discovery. The Company has signed multiple-year research agreements with clients including Pfizer, Organon and other pharmaceutical and biotech clients and is an indisputable leader in high value-added biology-based drug discovery CRO business in China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
HD Biosciences has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 8, 2008 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 8, 2008 Series A 1 Lilly Asia Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
HD Biosciences is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Yes Series A